Lipid Abnormalities and Association with Atopic Allergic Diseases
US-2024159778-A1 · May 16, 2024 · US
Modulating bacterial MAM polypeptides in pathogenic disease
US9529005B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9529005-B2 |
| Application number | US-201514861709-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 22, 2015 |
| Priority date | Apr 6, 2011 |
| Publication date | Dec 27, 2016 |
| Grant date | Dec 27, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a MAM polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for identifying or quantifying protein-lipid interaction on a membrane comprising contacting a membrane with a peptide or polypeptide comprising multivalent adhesion molecule (MAM) mce repeat region. 2. The method of claim 1 , wherein said peptide comprises 1, 2, 3, 4, 5, 6 or 7 mce repeat regions. 3. The method of claim 1 , wherein said peptide or polypeptide is labeled. 4. The method of…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
- G01N33/92Primary
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9529005B2 cover?
- The present invention relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a MAM polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
- Who is the assignee on this patent?
- Univ Texas
- What technology area does this patent fall under?
- Primary CPC classification G01N33/92. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).